Suppressed MKP-1 Is an Independent Predictor of Outcome in Patients with Hepatocellular Carcinoma
Eiji Tsujita(Kyushu University), Yoshihiko Maehara(Kyushu University), Akihiro Watanabe(Niigata Cancer Center Hospital), Tomonobu Gion(Kyushu University), Akinobu Taketomi(Hokkaido University), Yousuke Kuroda, Hideaki Nakashima(Fukuoka Dental College), Kazuya Endo(Fukuoka Dental College), Shin-ichi Aishima(Kyushu University), Shunji Kohnoe(Fukuoka Dental College)
Cited by 51
Related Papers
Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapy
|Cancer Science|2017|295
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267
Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)
|Journal of Hepato-Biliary-Pancreatic Sciences|2022|244